396

Compound name
Copanlisib
Alt Name
Aliqopa
Compound Image
Copanlisib.png
SMILES
COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5
Brutto
C23H28N8O4
InChI
InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32)
InChI Key
PZBCKZWLPGJMAO-UHFFFAOYSA-N
Approval Jurisdiction
2017 FDA
Approved for clinical use
Follicular Lymphoma
CAS
1032568-63-0
PubChem CID
24989044
Action
PI3k, mTOR
Approved Drug List
1
Commercial Vendor
Bayer